Market Research Logo

Diabetes Devices Market Analysis By Device Type (Self-monitoring & Diagnostic Devices (Lancets, Analog Glucose Meter, Continuous Glucose Monitor & Test Strips)), Delivery Type (Syringes, Pumps, Pens, Injectors) And Segment Forecasts To 2024

Diabetes Devices Market Analysis By Device Type (Self-monitoring & Diagnostic Devices (Lancets, Analog Glucose Meter, Continuous Glucose Monitor & Test Strips)), Delivery Type (Syringes, Pumps, Pens, Injectors) And Segment Forecasts To 2024

The global diabetes devices market size is expected to reach USD 35.5 billion by 2024, according to a new report by Grand View Research, Inc. The market is projected to expand at a CAGR of 7.0% during the forecast period. Growing cases of diabetes, due to obesity, sedentary and unhealthy lifestyles, and several other factors, is expected to drive demand for diabetes devices over the next few years.

Obesity is believed to be one of the foremost factors leading to diabetes in individuals. According to WHO, in 2014, over 1.9 billion people were identified to be overweight, of which, around 600 million people were obese.

Some of the key companies in the global diabetes devices market are Medtronic PLC, Sanofi S.A., Bayer Healthcare AG, Becton, Dickinson and Company, Novo Nordisk A/S, Abbott Laboratories, F. Hoffman-La Roche AG, and Johnson & Johnson.

Further key findings from the study suggest:

  • Constantly rising target population base is the primary factor driving market growth
  • Test strips capturedthe largest share in the monitoring and diagnostics device segment while insulin pens accounted for the largest revenue share among insulin delivery devices in 2016. This can be attributed to rapid adoption of these user-friendly, quick, and accurate devices for homecare use
  • North America is leading the regional market, followed by Europe. Advanced healthcare infrastructure and availability of technologically advanced products have driven the regional market
  • Key players in the market include Medtronic PLC, Sanofi S.A., Bayer Healthcare AG, Becton Dickinson and Company, Novo Nordisk A/S, Abbott Laboratories, F. Hoffman-La Roche AG and Johnson & Johnson.


Chapter 1 Research Methodology
1.1 Information procurement
1.2 Data Analysis
1.3 Approaches for market estimation
1.3.1 Approach 1: Demand Analysis & Bottom up Approach
1.3.2 Approach 2: Top down market estimation
1.3.3 Approach 3: Commodity flow and bottom up market estimation
1.3.4 Approach 4: KoL perspective based market sizing
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Industry Outlook
3.1 Market segmentation & scope
3.2 Market Driver Analysis
3.3 Market Restraint Analysis
3.4 Penetration & growth prospect mapping
3.5 Diabetes Devices - SWOT Analysis, By Factor (political & legal, economic and technological)
3.6 Industry Analysis - Porter’s
Chapter 4 Diabetes Devices Market: Product Estimates & Trend Analysis
4.1 Diabetes Devices market revenue share by product, 2014 & 2024, % share
4.2 Monitoring and Diagnostic Devices
4.2.1 Monitoring and Diagnostic Devices Market Revenue, by type, 2014 - 2024 (USD Million)
4.2.2 Lancets
4.2.2.1 Lancets Market Revenue, 2014 to 2024 (USD Million)
4.2.3 Analog Glucose Meter
4.2.3.1 Analog Glucose Meter Market Revenue, 2014 to 2024 (USD Million)
4.2.4 Continuous Glucose Monitor (CGM)
4.2.4.1 Continuous Glucose Monitor Market Revenue, 2014 to 2024 (USD Million)
4.2.5 Test Strips
4.2.5.1 Test Strips Market Revenue, 2014 to 2024 (USD Million)
4.3 Insulin Delivery Devices
4.3.1 Insulin Delivery Devices Market Revenue, 2014 to 2024 (USD Million)
4.3.2 Syringe
4.3.2.1 Syringe Market Revenue, 2014 to 2024 (USD Million)
4.3.3 Pen
4.3.3.1 Pen Market Revenue, 2014 to 2024 (USD Million)
4.3.4 Pump
4.3.4.1 Pump Market Revenue, 2014 to 2024 (USD Million)
4.3.5 Injector
4.3.5.1 Injector Market Revenue, 2014 to 2024 (USD Million)
Chapter 6 Diabetes Devices Market: Regional Estimates & Trend Analysis, by Product and End-Use
6.1 Diabetes Devices Market: Regional Movement Analysis
6.2 North America
6.2.1 North America market, 2014 - 2024 (USD Million)
6.2.2 U.S.
6.2.2.1 U.S. market, 2014 - 2024 (USD Million)
6.2.3 Canada
6.2.3.1 Canada market, 2014 - 2024 (USD Million)
6.3 Europe
6.3.1 Europe market, 2014 - 2024 (USD Million)
6.3.2 U.K.
6.3.2.1 U.K. market, 2014 - 2024 (USD Million)
6.3.3 Germany
6.3.3.1 Germany market, 2014 - 2024 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific market, 2014 - 2024 (USD Million)
6.4.2 China
6.4.2.1 China market, 2014 - 2024 (USD Million)
6.4.3 India
6.4.3.1 India market, 2014 - 2024 (USD Million)
6.5 Latin America
6.6 Latin America market, 2014 - 2024 (USD Million)
6.6.1 Brazil
6.6.1.1 Brazil market, 2014 - 2024 (USD Million)
6.6.2 Mexico
6.6.2.1 Mexico market, 2014 - 2024 (USD Million)
6.7 Middle East and Africa (MEA)
6.8 MEA market, 2014 - 2024 (USD Million)
6.8.1 South Africa
6.8.1.1 South Africa market, 2014 - 2024 (USD Million)
Chapter 7 Competitive Landscape
7.1 Strategy framework
7.2 Company Profiles
7.2.1 Abbott Laboratories Inc.
7.2.1.1 Company Overview
7.2.1.2 Fi nancial Performance
7.2.1.3 Product Benchmarking
7.2.1.4 Strategic Initiatives
7.2.2 F. Hoffmann-La Roche AG
7.2.2.1 Company Overview
7.2.2.2 Fi nancial Performance
7.2.2.3 Product Benchmarking
7.2.2.4 Strategic Initiatives
7.2.3 Johnson & Johnson
7.2.3.1 Company Overview
7.2.3.2 Financial Performance
7.2.3.3 Product Benchmarking
7.2.3.4 Strategic Initiatives
7.2.4 Bayer Healthcare AG
7.2.4.1 Company Overview
7.2.4.2 Financial Performance
7.2.4.3 Product Benchmarking
7.2.4.4 Strategic Initiatives
7.2.5 Becton, Dickinson and Company
7.2.5.1 Company Overview
7.2.5.2 Financial Performance
7.2.5.3 Product Benchmarking
7.2.5.4 Strategic Initiatives
7.2.6 Medtronic
7.2.6.1 Company Overview
7.2.6.2 Financial Performance
7.2.6.3 Product Benchmarking
7.2.6.4 Strategic Initiatives
7.2.7 Novo Nordisk A/S
7.2.7.1 Company Overview
7.2.7.2 Financial Performance
7.2.7.3 Product Benchmarking
7.2.7.4 Strategic Initiatives
7.2.8 Sanofi
7.2.8.1 Company Overview
7.2.8.2 Financial Performance
7.2.8.3 Product Benchmarking
7.2.8.4 Strategic Initiatives
List of Tables
TABLE 1 Diabetes Devices - Industry Snapshot & Key Buying Criteria, 2014 - 2024
TABLE 2 Diabetes Devices Market Revenue, by Product, 2014 - 2024 (USD Million)
TABLE 3 Diabetes Devices Market Revenue, by Region, 2014 - 2024 (USD Million)
TABLE 4 Diabetes Devices - Key Market Driver Analysis
TABLE 5 North America Diabetes Devices Market Revenue, by Product, 2014 - 2024 (USD Million)
TABLE 6 U.S. Diabetes Devices Market Revenue, by Monitoring and Diagnostic Devices, 2014 - 2024 (USD Million)
TABLE 7 U.S. Diagnostic Diabetes Devices Market Revenue, by Insulin Delivery Devices, 2014 - 2024 (USD Million)
TABLE 8 Canada Diabetes Devices Market Revenue, by Monitoring and Diagnostic Devices, 2014 - 2024 (USD Million)
TABLE 9 Canada Diagnostic Diabetes Devices Market Revenue, by Insulin Delivery Devices, 2014 - 2024 (USD Million)
TABLE 10 Europe Diabetes Devices Market Revenue, by Product, 2014 - 2024 (USD Million)
TABLE 11 U.K. Diabetes Devices Market Revenue, by Monitoring and Diagnostic Devices, 2014 - 2024 (USD Million)
TABLE 12 U.K. Diagnostic Diabetes Devices Market Revenue, by Insulin Delivery Devices, 2014 - 2024 (USD Million)
TABLE 13 Germany Diabetes Devices Market Revenue, by Monitoring And Diagnostic Devices, 2014 - 2024 (USD Million)
TABLE 14 Germany Diagnostic Diabetes Devices Market Revenue, by Insulin Delivery Devices, 2014 - 2024 (USD Million)
TABLE 15 Asia Pacific Diabetes Devices Market Revenue, by Product, 2014 - 2024 (USD Million)
TABLE 16 China Diabetes Devices Market Revenue, by Monitoring and Diagnostic Devices, 2014 - 2024 (USD Million)
TABLE 17 China Diabetes Devices Market Revenue, by Insulin Delivery Devices, 2014 - 2024 (USD Million)
TABLE 18 India Diabetes Devices Market Revenue, by Monitoring and Diagnostic Devices, 2014 - 2024 (USD Million)
TABLE 19 India Diagnostic Diabetes Devices Market Revenue, by Insulin Delivery Devices, 2014 - 2024 (USD Million)
TABLE 20 Latin America Diabetes Devices Market Revenue, by Product, 2014 - 2024 (USD Million)
TABLE 21 Brazil Diabetes Devices Market Revenue, by Monitoring And Diagnostic Devices, 2014 - 2024 (USD Million)
TABLE 22 Brazil Diagnostic Diabetes Devices Market Revenue, by Insulin Delivery Devices, 2014 - 2024 (USD Million)
TABLE 23 Mexico Diabetes Devices Market Revenue, by Monitoring And Diagnostic Devices, 2014 - 2024 (USD Million)
TABLE 24 Mexico Diagnostic Diabetes Devices Market Revenue, by Insulin Delivery Devices, 2014 - 2024 (USD Million)
TABLE 25 MEA Diabetes Devices Market Revenue, by Product, 2014 - 2024 (USD Million)
TABLE 26 South Africa Diabetes Devices Market Revenue, by Monitoring And Diagnostic Devices, 2014 - 2024 (USD Million)
TABLE 27 South Africa Diagnostic Diabetes Devices Market Revenue, by Insulin Delivery Devices, 2014 - 2024 (USD Million)
List of Figures
FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value-chain-based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Market segmentation & scope
FIG. 8 Global Diabetes Devices Market, 2014 - 2024, USD Million
FIG. 9 Diabetes Devices Market Dynamics
FIG. 10 Market driver relevance analysis (current & future impact)
FIG. 11 Key opportunities prioritized
FIG. 12 Diabetes devices market - Porter’s Analysis
FIG. 13 PESTLE Analysis
FIG. 14 Insulin delivery devices market: company market share analysis, 2015
FIG. 15 Value Chain Analysis
FIG. 16 Insulin syringes market, 2014 - 2024 (USD Million)
FIG. 17 Insulin pens market, 2014 - 2024 (USD Million)
FIG. 18 Insulin pumps market, 2014 - 2024 (USD Million)
FIG. 19 Insulin jet injectors market, 2014 - 2024 (USD Million)
FIG. 20 Regional outlook, 2015 & 2024

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report